(Q50539784)

15 March 2018

title

Modelling long-term persistence of hepatitis B antibodies after vaccination. (English)

1 reference

15 March 2018

author name string

Vellinga A

1

1 reference

15 March 2018

Van Damme P

2

1 reference

15 March 2018

Bruckers L

3

1 reference

15 March 2018

Weyler JJ

4

1 reference

15 March 2018

Molenberghs G

5

1 reference

15 March 2018

Meheus A

6

1 reference

15 March 2018

publication date

1 February 1999

1 reference

15 March 2018

Journal of Medical Virology

published in

1 reference

15 March 2018

volume

57

1 reference

15 March 2018

issue

2

1 reference

15 March 2018

page(s)

100-103

1 reference

15 March 2018

Scheduling of revaccination against hepatitis B virus

cites work

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199902%2957%3A2%3C100%3A%3AAID-JMV2%3E3.0.CO%3B2-M

Persistence of anti-HBs in children vaccinated against viral hepatitis B in the first year of life: follow-up at 5 and 10 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199902%2957%3A2%3C100%3A%3AAID-JMV2%3E3.0.CO%3B2-M

Immunological adverse effects of anticonvulsants. What is their clinical relevance?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199902%2957%3A2%3C100%3A%3AAID-JMV2%3E3.0.CO%3B2-M

Quantification of hepatitis B vaccine-induced antibodies as a predictor of anti-HBs persistence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199902%2957%3A2%3C100%3A%3AAID-JMV2%3E3.0.CO%3B2-M

Random-effects models, for longitudinal data using Gibbs sampling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199902%2957%3A2%3C100%3A%3AAID-JMV2%3E3.0.CO%3B2-M

Long term observation of the effect of intradermal hepatitis B vaccination on mentally retarded patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199902%2957%3A2%3C100%3A%3AAID-JMV2%3E3.0.CO%3B2-M

Nine-year follow-up study of a plasma-derived hepatitis B vaccine in a rural African setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199902%2957%3A2%3C100%3A%3AAID-JMV2%3E3.0.CO%3B2-M

Vaccine induced immunologic memory for hepatitis B surface antigen: implications for policy on booster vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199902%2957%3A2%3C100%3A%3AAID-JMV2%3E3.0.CO%3B2-M

Long-term immunogenicity and efficacy of hepatitis B vaccine in homosexual men

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199902%2957%3A2%3C100%3A%3AAID-JMV2%3E3.0.CO%3B2-M

Hepatitis B vaccination: how long does protection last?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199902%2957%3A2%3C100%3A%3AAID-JMV2%3E3.0.CO%3B2-M

Decline of anti-HBs after hepatitis B vaccination and timing of revaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199902%2957%3A2%3C100%3A%3AAID-JMV2%3E3.0.CO%3B2-M

Half-life of HBs antibody after hepatitis B vaccination: an aid to timing of booster vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199902%2957%3A2%3C100%3A%3AAID-JMV2%3E3.0.CO%3B2-M

Protection provided by hepatitis B vaccine in a Yupik Eskimo population--results of a 10-year study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199902%2957%3A2%3C100%3A%3AAID-JMV2%3E3.0.CO%3B2-M

10.1002/(SICI)1096-9071(199902)57:2<100::AID-JMV2>3.0.CO;2-M

21 January 2018

Identifiers

DOI

1 reference

15 March 2018

1 reference

15 March 2018